Andales, Floryn L.
HRN: 23-72-76 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/23/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/23/2023
09/29/2023
IVT
72mg
Q24
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes